Breaking News Instant updates and real-time market news.

FECCF

Frontera Energy

$0.00 /

+ (+0.00%)

13:55
08/07/20
08/07
13:55
08/07/20
13:55

Frontera Energy price target lowered to C$4 from C$4.50 at BMO Capital

BMO Capital analyst Mike Murphy lowered the firm's price target on Frontera Energy to C$4 from C$4.50 and keeps a Market Perform rating on the shares.

FECCF Frontera Energy
$0.00 /

+ (+0.00%)

03/06/20 BMO Capital
BMO reiterates Market Perform on Frontera after Q4 results
03/02/20 BMO Capital
Frontera Energy initiated with a Market Perform at BMO Capital

TODAY'S FREE FLY STORIES

Earnings
Insmed reports Q2 GAAP EPS ($1.07), consensus (85c) » 07:56
08/05/21
08/05
07:56
08/05/21
07:56
INSM

Insmed

$24.77 /

+0.75 (+3.12%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
INSM Insmed
$24.77 /

+0.75 (+3.12%)

INSM Insmed
$24.77 /

+0.75 (+3.12%)

04/26/21 Credit Suisse
Insmed assumed with an Outperform at Credit Suisse
02/22/21 Credit Suisse
United Therapeutics price target raised to $196 from $169 at Credit Suisse
01/19/21 Credit Suisse
Insmed price target raised to $60 from $50 at Credit Suisse
12/17/20 Berenberg
Insmed initiated with a Buy at Berenberg
INSM Insmed
$24.77 /

+0.75 (+3.12%)

  • 11
    May
INSM Insmed
$24.77 /

+0.75 (+3.12%)

Upgrade
Ascend Wellness upgraded to Buy from Speculative Buy at Canaccord » 07:55
08/05/21
08/05
07:55
08/05/21
07:55
AAWH

Ascend Wellness

/

+

Canaccord analyst Bobby…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Downgrade
Maxar Technologies downgraded to Hold from Buy at Canaccord » 07:55
08/05/21
08/05
07:55
08/05/21
07:55
MAXR

Maxar Technologies

$34.03 /

-1.32 (-3.73%)

Canaccord analyst Austin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MAXR Maxar Technologies
$34.03 /

-1.32 (-3.73%)

MAXR Maxar Technologies
$34.03 /

-1.32 (-3.73%)

06:46 Today Canaccord
Maxar Technologies downgraded to Hold from Buy at Canaccord
07/15/21 Morgan Stanley
Maxar Technologies initiated with an Overweight at Morgan Stanley
07/14/21 Baird
Baird starts Maxar Technologies at Neutral, cautious ahead of Legion launch
07/14/21 Baird
Maxar Technologies initiated with a Neutral at Baird
MAXR Maxar Technologies
$34.03 /

-1.32 (-3.73%)

  • 18
    Mar
MAXR Maxar Technologies
$34.03 /

-1.32 (-3.73%)

MAXR Maxar Technologies
$34.03 /

-1.32 (-3.73%)

MAXR Maxar Technologies
$34.03 /

-1.32 (-3.73%)

Recommendations
Uber price target lowered to $70 from $80 at Oppenheimer » 07:55
08/05/21
08/05
07:55
08/05/21
07:55
UBER

Uber

$41.79 /

-0.97 (-2.27%)

, LYFT

Lyft

$49.53 /

-5.855 (-10.57%)

Oppenheimer analyst Jason…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UBER Uber
$41.79 /

-0.97 (-2.27%)

LYFT Lyft
$49.53 /

-5.855 (-10.57%)

UBER Uber
$41.79 /

-0.97 (-2.27%)

06:56 Today Barclays
Uber should be bought on weakness, says Barclays
08/02/21
Fly Intel: Top five analyst initiations
08/02/21 Gordon Haskett
Gordon Haskett starts Uber at Buy, sees room for share gains across segments
08/02/21 Gordon Haskett
Uber initiated with a Buy at Gordon Haskett
LYFT Lyft
$49.53 /

-5.855 (-10.57%)

06:43 Today Citi
Lyft price target raised to $88 from $80 at Citi
08/04/21 BTIG
Lyft price target lowered to $75 from $80 at BTIG
08/04/21 Truist
Lyft price target raised to $80 from $76 at Truist
08/04/21 Cowen
Lyft price target raised to $80 from $76 at Cowen
UBER Uber
$41.79 /

-0.97 (-2.27%)

LYFT Lyft
$49.53 /

-5.855 (-10.57%)

  • 29
    Jul
  • 08
    Jan
UBER Uber
$41.79 /

-0.97 (-2.27%)

LYFT Lyft
$49.53 /

-5.855 (-10.57%)

UBER Uber
$41.79 /

-0.97 (-2.27%)

LYFT Lyft
$49.53 /

-5.855 (-10.57%)

UBER Uber
$41.79 /

-0.97 (-2.27%)

LYFT Lyft
$49.53 /

-5.855 (-10.57%)

Earnings
Black Knight reports Q2 adjusted EPS 57c, consensus 54c » 07:55
08/05/21
08/05
07:55
08/05/21
07:55
BKI

Black Knight

$82.68 /

+0.34 (+0.41%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BKI Black Knight
$82.68 /

+0.34 (+0.41%)

BKI Black Knight
$82.68 /

+0.34 (+0.41%)

05/07/21 William Blair
Black Knight selloff brings attractive entry point, says William Blair
04/19/21 Barclays
Black Knight shares nearing 'conviction buy levels,' says Barclays
04/13/21
Fly Intel: Top five analyst initiations
04/13/21 Raymond James
Black Knight initiated with a Market Perform at Raymond James
BKI Black Knight
$82.68 /

+0.34 (+0.41%)

Earnings
IES Holdings reports Q3 adjusted EPS 99c vs 60c last year » 07:55
08/05/21
08/05
07:55
08/05/21
07:55
IESC

IES Holdings

$54.02 /

-0.57 (-1.04%)

Reports Q3 revenue $406M…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IESC IES Holdings
$54.02 /

-0.57 (-1.04%)

IESC IES Holdings
$54.02 /

-0.57 (-1.04%)

Earnings
Aldeyra reports Q2 EPS (28c), consensus (24c) » 07:55
08/05/21
08/05
07:55
08/05/21
07:55
ALDX

Aldeyra

$8.83 /

-0.11 (-1.23%)

Cash and cash equivalents…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALDX Aldeyra
$8.83 /

-0.11 (-1.23%)

ALDX Aldeyra
$8.83 /

-0.11 (-1.23%)

04/28/21 Citi
Aldeyra price target raised to $25 from $22 at Citi
03/12/21 SVB Leerink
Aldeyra initiated with an Outperform at SVB Leerink
03/12/21 Citi
Aldeyra shares should double on data readouts this year, says Citi
02/08/21 H.C. Wainwright
Aldeyra initiated with a Buy at H.C. Wainwright
ALDX Aldeyra
$8.83 /

-0.11 (-1.23%)

  • 29
    Apr
  • 14
    Jan
ALDX Aldeyra
$8.83 /

-0.11 (-1.23%)

ALDX Aldeyra
$8.83 /

-0.11 (-1.23%)

General news
U.S. Challenger reported announced layoffs declined -1.5k to 18.9k in July » 07:55
08/05/21
08/05
07:55
08/05/21
07:55
$ECON

Economic Data

/

+

U.S. Challenger reported…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

Earnings
Zix reports Q2 EPS 10c, consensus 14c » 07:54
08/05/21
08/05
07:54
08/05/21
07:54
ZIXI

Zix

$7.30 /

-0.08 (-1.08%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ZIXI Zix
$7.30 /

-0.08 (-1.08%)

02/01/21 Stephens
Zix initiated with an Overweight at Stephens
ZIXI Zix
$7.30 /

-0.08 (-1.08%)

ZIXI Zix
$7.30 /

-0.08 (-1.08%)

Earnings
Starwood Property reports Q2 distributable EPS 51c, consensus 51c » 07:53
08/05/21
08/05
07:53
08/05/21
07:53
STWD

Starwood Property

$25.82 /

-0.21 (-0.81%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
STWD Starwood Property
$25.82 /

-0.21 (-0.81%)

08/04/21 JMP Securities
Starwood Property price target raised to $28 from $17 at JMP Securities
05/10/21 JPMorgan
Starwood Property price target raised to $26 from $25 at JPMorgan
04/26/21 JPMorgan
Starwood Property price target raised to $25 from $22 at JPMorgan
02/26/21 JPMorgan
Starwood Property price target raised to $22 from $21 at JPMorgan
STWD Starwood Property
$25.82 /

-0.21 (-0.81%)

Earnings
Salarius Pharmaceuticals reports Q2 EPS (7c), consensus (6c) » 07:53
08/05/21
08/05
07:53
08/05/21
07:53
SLRX

Salarius Pharmaceuticals

/

+

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SLRX Salarius Pharmaceuticals
/

+

  • 04
    Mar
Recommendations
Amdocs price target raised to $99 from $84 at Oppenheimer » 07:53
08/05/21
08/05
07:53
08/05/21
07:53
DOX

Amdocs

$75.03 /

-1.23 (-1.61%)

Oppenheimer analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DOX Amdocs
$75.03 /

-1.23 (-1.61%)

DOX Amdocs
$75.03 /

-1.23 (-1.61%)

04/01/21 JPMorgan
Amdocs should 'bounce-back' after short report, says JPMorgan
03/31/21 JPMorgan
Prior Amdocs short report turned out a 'great buying opportunity,' says JPMorgan
02/11/21 Oppenheimer
Amdocs assumed with an Outperform at Oppenheimer
02/03/21 Citi
Amdocs price target raised to $87 from $82 at Citi
DOX Amdocs
$75.03 /

-1.23 (-1.61%)

DOX Amdocs
$75.03 /

-1.23 (-1.61%)

Recommendations
Horizon Therapeutics price target raised to $132 from $118 at BMO Capital » 07:52
08/05/21
08/05
07:52
08/05/21
07:52
HZNP

Horizon Therapeutics

$107.54 /

+7.79 (+7.81%)

BMO Capital analyst Gary…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HZNP Horizon Therapeutics
$107.54 /

+7.79 (+7.81%)

HZNP Horizon Therapeutics
$107.54 /

+7.79 (+7.81%)

06:28 Today Citi
Horizon Therapeutics price target raised to $121 from $117 at Citi
07/16/21 Piper Sandler
Horizon's Krystexxa poised for 'aggressive growth,' says Piper Sandler
06/21/21 Piper Sandler
Arrowhead price target raised to $109 from $99 at Piper Sandler
05/05/21 Cowen
Cowen would add to Horizon Therapeutics after 'nicely conservative' guidance
HZNP Horizon Therapeutics
$107.54 /

+7.79 (+7.81%)

  • 07
    Aug
Earnings
Quanta Services raises FY21 adjusted EPS view to $4.32-$4.68 from $4.12-$4.57 » 07:52
08/05/21
08/05
07:52
08/05/21
07:52
PWR

Quanta Services

$89.05 /

-2.17 (-2.38%)

Consensus $4.42. Raises…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PWR Quanta Services
$89.05 /

-2.17 (-2.38%)

PWR Quanta Services
$89.05 /

-2.17 (-2.38%)

07/22/21 Citi
Citi opens 'positive catalyst watch' on Quanta Services into earnings
07/19/21 Cowen
Quanta Services initiated with an Outperform at Cowen
06/25/21 Citi
Citi sees infrastructure framework as 'tailwind' for infrastructure companies
06/08/21
Fly Intel: Top five analyst initiations
PWR Quanta Services
$89.05 /

-2.17 (-2.38%)

PWR Quanta Services
$89.05 /

-2.17 (-2.38%)

PWR Quanta Services
$89.05 /

-2.17 (-2.38%)

PWR Quanta Services
$89.05 /

-2.17 (-2.38%)

Hot Stocks
Arbutus Biopharma expects cash to fund operations into Q3 of 2022 » 07:52
08/05/21
08/05
07:52
08/05/21
07:52
ABUS

Arbutus Biopharma

$2.76 /

+0.01 (+0.36%)

Arbutus had cash, cash…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ABUS Arbutus Biopharma
$2.76 /

+0.01 (+0.36%)

ABUS Arbutus Biopharma
$2.76 /

+0.01 (+0.36%)

06/28/21 JMP Securities
Arbutus EASL updates still support progress in Chronic HBV, says JMP Securities
03/10/21 B. Riley Securities
Arbutus Biopharma price target lowered to $7 from $8 at B. Riley Securities
12/17/20 H.C. Wainwright
Arbutus Biopharma initiated with a Buy at H.C. Wainwright
09/15/20 Chardan
Arbutus HBV data 'could represent a turning point,' says Chardan
ABUS Arbutus Biopharma
$2.76 /

+0.01 (+0.36%)

ABUS Arbutus Biopharma
$2.76 /

+0.01 (+0.36%)

Earnings
OGE Energy backs FY21 EPS in 'lower half' of $1.76-$1.86, consensus $2.18 » 07:51
08/05/21
08/05
07:51
08/05/21
07:51
OGE

OGE Energy

$34.10 /

-0.265 (-0.77%)

The company reaffirms its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OGE OGE Energy
$34.10 /

-0.265 (-0.77%)

OGE OGE Energy
$34.10 /

-0.265 (-0.77%)

06/11/21 BofA
OGE Energy upgraded to Buy from Neutral at BofA
05/25/21 Barclays
OGE Energy upgraded to Equal Weight from Underweight at Barclays
03/11/21 BofA
OGE Energy downgraded to Neutral from Buy at BofA
03/09/21 Wells Fargo
OGE Energy downgraded to Equal Weight at Wells Fargo
OGE OGE Energy
$34.10 /

-0.265 (-0.77%)

Earnings
Provention Bio reports Q2 EPS (46c), consensus (52c) » 07:51
08/05/21
08/05
07:51
08/05/21
07:51
PRVB

Provention Bio

$6.02 /

-0.195 (-3.14%)

Provention Bio expects…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PRVB Provention Bio
$6.02 /

-0.195 (-3.14%)

PRVB Provention Bio
$6.02 /

-0.195 (-3.14%)

07/09/21 Chardan
Provention Bio coverage transferred at Chardan
05/28/21 Chardan
Provention Bio price target lowered to $22.50 from $35 at Chardan
05/25/21 SVB Leerink
Provention Bio briefing documents a positive, says SVB Leerink
05/07/21 Cantor Fitzgerald
Provention Bio price target lowered to $19 from $25 at Cantor Fitzgerald
PRVB Provention Bio
$6.02 /

-0.195 (-3.14%)

  • 14
    Jan
PRVB Provention Bio
$6.02 /

-0.195 (-3.14%)

PRVB Provention Bio
$6.02 /

-0.195 (-3.14%)

Recommendations
Allogene Therapeutics price target lowered to $44 from $52 at Oppenheimer » 07:51
08/05/21
08/05
07:51
08/05/21
07:51
ALLO

Allogene Therapeutics

$22.13 /

+0.23 (+1.05%)

Oppenheimer analyst Mark…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALLO Allogene Therapeutics
$22.13 /

+0.23 (+1.05%)

ALLO Allogene Therapeutics
$22.13 /

+0.23 (+1.05%)

05:29 Today Oppenheimer
Allogene Therapeutics price target lowered to $44 from $52 at Oppenheimer
06/21/21 Jefferies
Allogene Therapeutics assumed with a Buy at Jefferies
05/20/21 Jefferies
Allogene update exceeds expectation 'on all fronts,' says Jefferies
05/20/21 Stifel
Allogene data 'better than they appear on the surface,' says Stifel
ALLO Allogene Therapeutics
$22.13 /

+0.23 (+1.05%)

ALLO Allogene Therapeutics
$22.13 /

+0.23 (+1.05%)

Earnings
Arbutus Biopharma reports Q2 EPS (23c), consensus (22c) » 07:51
08/05/21
08/05
07:51
08/05/21
07:51
ABUS

Arbutus Biopharma

$2.76 /

+0.01 (+0.36%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ABUS Arbutus Biopharma
$2.76 /

+0.01 (+0.36%)

ABUS Arbutus Biopharma
$2.76 /

+0.01 (+0.36%)

06/28/21 JMP Securities
Arbutus EASL updates still support progress in Chronic HBV, says JMP Securities
03/10/21 B. Riley Securities
Arbutus Biopharma price target lowered to $7 from $8 at B. Riley Securities
12/17/20 H.C. Wainwright
Arbutus Biopharma initiated with a Buy at H.C. Wainwright
09/15/20 Chardan
Arbutus HBV data 'could represent a turning point,' says Chardan
ABUS Arbutus Biopharma
$2.76 /

+0.01 (+0.36%)

ABUS Arbutus Biopharma
$2.76 /

+0.01 (+0.36%)

Earnings
Stratasys sees Q3 revenue growth 17% - 18% growth year-over-year » 07:51
08/05/21
08/05
07:51
08/05/21
07:51
SSYS

Stratasys

$19.70 /

+0.07 (+0.36%)

Sees Q3 revenue of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SSYS Stratasys
$19.70 /

+0.07 (+0.36%)

SSYS Stratasys
$19.70 /

+0.07 (+0.36%)

03/26/21 Lake Street
Desktop Metal initiated with a Sell at Lake Street
03/12/21 Lake Street
Stratasys initiated with a Buy at Lake Street
03/10/21 JPMorgan
Stratasys upgraded to Neutral after 50% pullback at JPMorgan
03/10/21 JPMorgan
Stratasys upgraded to Neutral from Underweight at JPMorgan
SSYS Stratasys
$19.70 /

+0.07 (+0.36%)

  • 03
    Mar
SSYS Stratasys
$19.70 /

+0.07 (+0.36%)

SSYS Stratasys
$19.70 /

+0.07 (+0.36%)

Upgrade
Morgan Stanley upgrades Virtus Investment to Overweight on better EPS growth » 07:51
08/05/21
08/05
07:51
08/05/21
07:51
VRTS

Virtus Investment

$285.16 /

+3.42 (+1.21%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VRTS Virtus Investment
$285.16 /

+3.42 (+1.21%)

VRTS Virtus Investment
$285.16 /

+3.42 (+1.21%)

05:16 Today Morgan Stanley
Virtus Investment upgraded to Overweight from Equal Weight at Morgan Stanley
02/03/21 Barclays
Virtus Investment price target raised to $315 from $280 at Barclays
01/25/21 Barclays
Virtus Investment price target raised to $280 from $270 at Barclays
10/26/20 Barclays
Virtus Investment price target raised to $215 from $180 at Barclays
VRTS Virtus Investment
$285.16 /

+3.42 (+1.21%)

Earnings
InflaRx reports Q2 EPS (EUR0.33) vs. (EUR0.38) last year » 07:50
08/05/21
08/05
07:50
08/05/21
07:50
IFRX

InflaRx

$2.49 /

-0.03 (-1.19%)

"I am very pleased…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IFRX InflaRx
$2.49 /

-0.03 (-1.19%)

IFRX InflaRx
$2.49 /

-0.03 (-1.19%)

03/26/21 H.C. Wainwright
InflaRx price target lowered to $10 from $12 at H.C. Wainwright
03/11/21 Guggenheim
InflaRx upgraded to Buy from Neutral at Guggenheim
01/12/21 H.C. Wainwright
InflaRx price target raised to $12 from $11 at H.C. Wainwright
11/06/20 SVB Leerink
InflaRx upgraded to Outperform from Market Perform at SVB Leerink
IFRX InflaRx
$2.49 /

-0.03 (-1.19%)

  • 25
    Feb
Earnings
OGE Energy reports Q2 EPS 56c, consensus 53c » 07:50
08/05/21
08/05
07:50
08/05/21
07:50
OGE

OGE Energy

$34.10 /

-0.265 (-0.77%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OGE OGE Energy
$34.10 /

-0.265 (-0.77%)

OGE OGE Energy
$34.10 /

-0.265 (-0.77%)

06/11/21 BofA
OGE Energy upgraded to Buy from Neutral at BofA
05/25/21 Barclays
OGE Energy upgraded to Equal Weight from Underweight at Barclays
03/11/21 BofA
OGE Energy downgraded to Neutral from Buy at BofA
03/09/21 Wells Fargo
OGE Energy downgraded to Equal Weight at Wells Fargo
OGE OGE Energy
$34.10 /

-0.265 (-0.77%)

Earnings
Quanta Services reports Q2 adjusted EPS $1.06, consensus $1.04 » 07:50
08/05/21
08/05
07:50
08/05/21
07:50
PWR

Quanta Services

$89.05 /

-2.17 (-2.38%)

Reports Q2 revenue $3B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PWR Quanta Services
$89.05 /

-2.17 (-2.38%)

PWR Quanta Services
$89.05 /

-2.17 (-2.38%)

07/22/21 Citi
Citi opens 'positive catalyst watch' on Quanta Services into earnings
07/19/21 Cowen
Quanta Services initiated with an Outperform at Cowen
06/25/21 Citi
Citi sees infrastructure framework as 'tailwind' for infrastructure companies
06/08/21
Fly Intel: Top five analyst initiations
PWR Quanta Services
$89.05 /

-2.17 (-2.38%)

PWR Quanta Services
$89.05 /

-2.17 (-2.38%)

PWR Quanta Services
$89.05 /

-2.17 (-2.38%)

PWR Quanta Services
$89.05 /

-2.17 (-2.38%)

Recommendations
Sealed Air price target raised to $62 from $52 at BMO Capital » 07:50
08/05/21
08/05
07:50
08/05/21
07:50
SEE

Sealed Air

$57.99 /

-0.54 (-0.92%)

BMO Capital analyst Mark…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SEE Sealed Air
$57.99 /

-0.54 (-0.92%)

SEE Sealed Air
$57.99 /

-0.54 (-0.92%)

08/03/21 BofA
Sealed Air price target raised to $72 from $67 at BofA
05/06/21 BMO Capital
Sealed Air price target raised to $52 from $42 at BMO Capital
05/05/21
Fly Intel: Top five analyst upgrades
05/05/21 Baird
Sealed Air price target raised to $72 from $56 at Baird
SEE Sealed Air
$57.99 /

-0.54 (-0.92%)

SEE Sealed Air
$57.99 /

-0.54 (-0.92%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.